Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13326236 | 0.79 | CFTR (0.41) | MEN1KMT2ACFTRGOPCCHRM2 | |
| SCHEMBL1997816 | 0.67 | CHRM2 (0.33) | HCAR2CHRM2CHRM4HCAR3 | |
| SCHEMBL9248402 | 0.64 | HSD11B1 (0.43) | MEN1KMT2ACYP2C9 | |
| SCHEMBL28921927 | 0.62 | HCAR2 (0.34) | HCAR2 | |
| SCHEMBL7103224 | 0.60 | ALDH1A1 (0.41) | HCAR2ELANEMEN1KMT2AHCAR3 | |
| SCHEMBL7777523 | 0.60 | L3MBTL1 (0.45) | CHRM2CHRM4CYP2C9 | |
| SCHEMBL7635908 | 0.60 | CFTR (0.56) | HCAR2MEN1KMT2ACFTRGOPC | |
| SCHEMBL7559609 | 0.59 | AKR1C1 (0.38) | MEN1KMT2A | |
| SCHEMBL9304904 | 0.58 | CFTR (0.54) | HCAR2MEN1KMT2ACFTRGOPC | |
| SCHEMBL13745023 | 0.56 | OPRM1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1127043-A1 | STEREOSELECTIVE PROCESS FOR PREPARING (CYCLO)ALKYL PHENYLGLYCOLIC ACIDS | Sepracor Inc. (US) | 2001-08-29 | — | — | EP | claimed |
| US-6180823-B1 | CONDENSING SUBSTITUTED ACETALDEHYDE WITH ENANTIOMER OF MANDELIC ACID TO PROVIDE 5-PHENYL-1,3-DIOXOLAN-4-ONE, CONDENSING WITH CYCLOHEXANONE, DEHYDRATING PRODUCT, HYDROLYZING, REDUCING TO ALPHA-CYCLOHEXYLPHENYLGLYCOLIC ACID | SEPRACOR INC. | 2001-01-30 | — | — | US | claimed |
| WO-2000027786-A1 | STEREOSELECTIVE PROCESS FOR PREPARING (CYCLO)ALKYL PHENYLGLYCOLIC ACIDS | SEPRACOR INC. (US) | 2000-05-18 | — | — | WO | claimed |
| EP-1191930-A2 | METHODS FOR TREATMENT OF ASTHMA USING S-OXYBUTYNIN | Sepracor Inc. (US) | 2002-04-03 | — | — | EP | disclosed |
| US-6294582-B1 | THERAPY OF REVERSIBLE OBSTRUCTIVE PULMONARY DISEASE BY ADMINISTERING OPTICALLY PURE S-OXYBUTYNIN OR ITS SALT | SEPRACOR INC. | 2001-09-25 | — | — | US | disclosed |
| WO-2000076490-A2 | METHODS AND COMPOSITIONS FOR TREATING URINARY FREQUENCY AND URGENCY USING OPTICALLY PURE (S)-OXYBUTYNIN | SEPRACOR INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000071108-A2 | METHODS FOR TREATMENT OF ASTHMA USING S-OXYBUTYNIN | SEPRACOR INC. (US) | 2000-11-30 | — | — | WO | disclosed |